Marcin Frąckiewicz

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company working with customers worldwide. His experience spans satellite communications, telecommunications and technology ventures. He graduated from the Warsaw School of Economics (SGH) and writes about space technology, artificial intelligence, stocks and the technology companies and industries he follows. Follow Marcin Frąckiewicz on Google News, Facebook or LinkedIn.

Apple’s Big October Bombshells: Vision Pro 2, M5 MacBook Surprise, and an AI Push Shaking Up Tech

Apple’s Big October Bombshells: Vision Pro 2, M5 MacBook Surprise, and an AI Push Shaking Up Tech

Apple has surprised fans with a late-year hardware refresh centered on its next-generation M5 processor. In lieu of a live event, Apple issued a blitz of Newsroom announcements on October 15 introducing an entry-level 14‑inch MacBook Pro, updated 11″ and 13″ iPad Pro models, and a modestly upgraded Apple Vision Pro headset – all powered by the new M5 chiptechcrunch.comtechcrunch.com. The M5 is a significant leap forward: Apple says it delivers over 4× the peak GPU performance of the previous M4 generation, and Apple SVP Johny Srouji touted that the M5 “ushers in the next big leap in AI performance for Apple silicon.”techcrunch.com
17 October 2025
·
Oracle’s AI Cloud Blitz: $300B OpenAI Deal, Meta Pact, and Supercomputer Unveiled

Oracle’s AI Cloud Blitz: $300B OpenAI Deal, Meta Pact, and Supercomputer Unveiled

Oracle has seized center stage in the artificial intelligence race by securing eye-popping cloud contracts to host and train the world’s most advanced AI models. In a move that stunned the tech industry, OpenAI – creator of ChatGPT – agreed to spend a reported $300 billion on Oracle Cloud over five yearsreuters.com. If fully realized, it ranks as one of the largest cloud deals ever and instantly turbocharges Oracle’s cloud business. This year Oracle also inked a major partnership with Meta Platforms, which committed roughly $65 billion for Oracle’s cloud services as Meta expands its AI infrastructureainvest.com. Both deals were highlighted during Oracle’s AI World conference in Las Vegas and signal that global AI leaders trust Oracle to deliver critical computing power.
17 October 2025
···
Nvidia’s AI Empire Unleashed: Mini Supercomputers, Mega-Deals and a Global Chip Arms Race

Nvidia’s AI Empire Unleashed: Mini Supercomputers, Mega-Deals and a Global Chip Arms Race

Nvidia’s dominance in AI computing has led to both blockbuster partnerships and fierce competition in recent weeks. The most dramatic development is Nvidia’s sweeping alliance with OpenAI – a deal valued at up to $100 billion that intertwines the leading AI chip supplier with the maker of ChatGPT ts2.tech ts2.tech. Under the agreement, announced late September, Nvidia will take a sizable stake in OpenAI and in return OpenAI commits to buying Nvidia’s cutting-edge GPUs to build out an unprecedented 10 gigawatts of AI supercomputing capacity ts2.tech ts2.tech. “Everything starts with compute,” OpenAI CEO Sam Altman said, emphasizing that vast processing power is key to future breakthroughs ts2.tech. Industry analysts have noted the circular nature of this pact – essentially Nvidia is funding OpenAI so OpenAI can spend that money on Nvidia hardware, locking in a huge long-term customer ts2.tech. Stacy Rasgon, a veteran chip analyst, called it an unusual strategy that virtually guarantees demand for Nvidia’s products, even as it raises eyebrows among regulators ts2.tech.
17 October 2025
··
RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX Stock Defies Market Slump as Engine ‘Game-Changer’ and Defense Deals Fuel Rally

RTX Corporation enters late October 2025 with solid momentum: a major engine launch cleared for takeoff, booming demand for its defense systems, and an upcoming earnings report that could affirm its growth trajectory. The stock’s slight rally on Oct. 17 – bucking a broader market downturn – signals that traders are focusing on RTX’s fundamentals and news flow rather than short-term macro jitters. To sustain this optimism, RTX’s management will need to show that profits are keeping pace with revenues amid inflation and that operational challenges are under control. If Q3 results beat expectations and guidance is upbeat, RTX stock could make another run toward its highs. Conversely, any negative surprises or cautious outlook might prompt a pullback given the stock’s recent strength.
17 October 2025
···
Intel Stock Soars on AI Hype and Big Backers – Will the Rally Last?

Intel Stock Soars on AI Hype and Big Backers – Will the Rally Last?

Intel’s share price has been on a roller-coaster in recent days, reflecting both excitement and caution. As of market close on Oct. 17, INTC traded in the high-$36 rangets2.tech, roughly flat for the week. The stock briefly spiked toward $38 earlier in the month – a new 52-week high – after reports that Intel was in talks to have AMD as a chip fabrication customerts2.tech. That October 2 report sent Intel up almost 4% intradayts2.tech, but gains faded when Deutsche Bank quickly warned the stock was overextended at those levels, urging investors to take profitsts2.tech.
17 October 2025
··
IBM Stock Hits Multi-Year High on AI & Quantum Hype – Can the Rally Last?

IBM Stock Hits Multi-Year High on AI & Quantum Hype – Can the Rally Last?

International Business Machines has staged a remarkable comeback in 2025. After languishing for much of the past decade, IBM’s stock has roared back to life, reaching levels not seen in years. It briefly hit an intraday high of ~$296 in late September when news of a quantum computing feat with HSBC sparked a 5% one-day jumpts2.techts2.tech. Even with a minor dip in mid-October, IBM trades only a few percent below that peak. Year-to-date, the shares are up roughly 28% – a huge move for such a mature tech giant – compared to about +13% for the broader marketts2.tech. In fact, IBM’s stock price touched record highs above $300 this yearts2.tech, a milestone that seemed far-fetched not long ago.
17 October 2025
····
Cisco Rides AI Wave as Stock Nears Year-High – What’s Next for CSCO?

Cisco Rides AI Wave as Stock Nears Year-High – What’s Next for CSCO?

Cisco’s stock is trading at $69 as of Friday, Oct. 17, 2025, putting it just a few dollars shy of its 1-year peakmarketbeat.com. This marks a strong run for the networking giant – shares have risen about 30% over the past year, easily outperforming the broader market. In the week leading up to Oct. 17, CSCO gained roughly 2%, reflecting optimism around the company’s recent announcements and financial results. The stock’s 12-month high is $72.55 and the low is $52.11marketbeat.com, so current prices indicate investors have driven the stock toward the upper end of its range. Cisco’s market capitalization stands around $270+ billion, making it one of the larger tech companies, though still valued more conservatively than some high-growth peers.
17 October 2025
···
Alibaba’s 2025 Comeback: AI Ambitions Fuel BABA Stock Rally – Will It Last?

Alibaba’s 2025 Comeback: AI Ambitions Fuel BABA Stock Rally – Will It Last?

Alibaba’s stock is capping off a strong week, with a notable move on October 17, 2025. The NYSE-listed BABA shares closed around $167 on Friday, recovering from early-session weakness. This roughly 3% intraday rebound came despite a sell-off in Hong Kong, where Alibaba’s secondary listing fell over 4% amid broad tech declines. Even with recent volatility, Alibaba’s U.S. stock remains near multi-year highs – up about 85–90% year-to-datets2.tech. By comparison, the NYSE Composite index is only up ~12% in 2025ts2.tech, underscoring Alibaba’s outsized rally. The stock’s momentum since spring carried it above key technical levels, and it now trades well above its 50- and 200-day moving averagests2.tech. Short-term indicators like RSI have flashed overbought, but pullbacks have been shallow so farts2.tech.
17 October 2025
····
Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Oscar Health Stock Skyrockets on AI-Fuelled Growth Plans – Analysts Warn of ACA Risks

Key Facts: - Oscar Health shares have surged in early October 2025, recently trading around $21–22ts2.techmarketbeat.com. The stock hit about $21.50 on Oct 3 and was trading near $21.76 on Oct 14ts2.techmarketbeat.com. - Oscar announced a $410 million convertible debt offering in September 2025 to fund AI-driven technology and growth initiativests2.tech. Proceeds will back “strategic initiatives focused on AI” and expansion of member servicesbusinesswire.comts2.tech. - The company also forged a major partnership with Midwestern grocer Hy‑Vee: launching “Hy‑Vee Health with Oscar”, an employer health plan in Iowa. CEO Mark Bertolini quipped coverage should be “as easy as buying milk at Hy‑Vee”ts2.techbusinesswire.com. - In Q2 2025 Oscar’s revenue jumped ~28–30% YoY to about $2.86–2.9 billion, but losses widened: a $228 million net loss on a high 91.1% medical-loss ratiots2.techts2.tech. Full‑year 2025 revenue guidance was raised to ~$12.0–12.2 B with an expected operating loss of $200–300 M, as Oscar adjusts pricing for higher claim coststs2.techts2.tech. - Wall Street remains cautious. No analysts rate OSCR a “Buy” – the consensus is “Strong Sell” with an average 12‑month price target of only ~$12ts2.techts2.tech. Major firms like UBS, Wells Fargo and Barclays have set low targets and warned of ACA market headwindsts2.techts2.tech. - Policy tailwinds
17 October 2025
··
Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Reddit Stock Rockets and Slumps: RDDT’s Wild Ride in 2025

Reddit’s stock has been highly volatile. After its monster summer rally, RDDT pulled back sharply in early October. In mid-September 2025 it briefly hit a $282.95 recordts2.tech, but profit-taking and tech-sector jitters drove it back toward the $190s by Oct 17. On Oct 17, midday trading saw RDDT around $190.44, roughly 4.3% lower for the daystockanalysis.com. Year-to-date the stock is still up roughly 244%ts2.tech, far outperforming the S&P 500 and Nasdaq indices. Since the March 2024 IPO, RDDT is up more than six-foldts2.techreuters.com – a blistering return even by tech standards.
17 October 2025
SoundHound AI Stock Slides 10% After CFO Cashes In – Can the 240% AI Rally Survive?

SoundHound AI Stock Slides 10% After CFO Cashes In – Can the 240% AI Rally Survive?

SoundHound AI stock sank on Friday after news of insider selling, undercutting some of the recent euphoria. The company’s Chief Financial Officer, Nitesh Sharan, disclosed he sold 60,376 SoundHound shares at an average ~$21.21indexbox.io. The sale, executed under a pre-arranged 10b5-1 trading plan, reduced the CFO’s direct stake by about 3.3%indexbox.io. The market reacted swiftly: SOUN fell ~6.9% in morning trading on Oct. 17 following the disclosure, and by afternoon it was trading around $18.80, roughly 9–10% below the prior day’s closeindexbox.ioindexbox.io.
17 October 2025
·
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead’s share price has been on a tear in recent weeks, reaching new highs for 2025. By mid-day October 17, GILD was up about 4.7% to roughly $123 per share Benzinga. Year-to-date, the stock has rallied nearly 47%, adding tens of billions to Gilead’s market value Stockanalysis. This far outpaces the single-digit gain of the Nasdaq Biotechnology Index over the same period Stockanalysis Invesco. Investors have cheered a string of positive catalysts: strong earnings, a fortified HIV franchise, and growing pipeline prospects.
17 October 2025
··
Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Rekor Systems (REKR) Stock Rockets 73% on AI-Powered Roadway Tech Breakthroughs

Stock Performance & Recent Moves: Rekor stock has surged lately on a combination of upbeat corporate news and broader tech buzz. After closing around $2.60 on Oct. 16, REKR jumped roughly 20% on Oct. 17tradingview.com. This continued a steep one-month rally: TS2.tech notes the shares have climbed about 73% in the past 30 daysts2.tech. This meteoric rise came as the company previewed blowout third-quarter results and rolled out new contracts. Wall Street observers say the valuation – now about 5.8× sales – appears “fair” relative to peers given Rekor’s growth outlookts2.tech.
17 October 2025
··
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

ts2.techLiberty Energy’s stock has seen a dramatic swing in recent weeks. After grinding lower for most of 2025 – at one point down over 40% year-to-date – LBRT caught a bid in October, climbing roughly 15% during the monthts2.tech. The rally accelerated on October 17 when the company’s latest earnings sparked a burst of buying. Intraday, LBRT shares jumped into the mid-$15 range, marking a one-day gain of more than 20%.
17 October 2025
····
Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

Bitcoin Crash Conspiracy? New Evidence Exposes Massive Crypto Market Manipulation

In sum, the mid-October “crypto Black Friday” crash has ignited a firestorm of questions about market manipulation and the fragility of trading infrastructure. Evidence of suspicious whale trades, exchange glitches, and perfectly-timed exploits suggest that the rout may have been at least partly orchestrated, rather than a natural response to bad news. Regulators are under pressure to scrutinize what really happened behind the scenes. The crypto market, meanwhile, is gingerly finding its footing again. Bitcoin’s price is well off its highs but signs of resilience – from hodlers doubling down to institutional money staying put – offer hope that the bull run isn’t over. Whether this event goes down in history as a one-off “perfect storm” or the start of a new era of oversight in crypto markets, one lesson is clear: in the wild world of crypto, not everything is as it seems on the surfacecryptodnes.bgbeincrypto.com.
17 October 2025
····
XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

XORTX Therapeutics (XRTX) Stock Skyrockets on Kidney Drug Deal – Key Facts & Outlook

Shares of XORTX Therapeutics Inc. surged on October 17, 2025 after the nano-cap biotech announced a strategic acquisition in its core therapeutic area. The stock rocketed up immediately following the morning press release, spiking up to 40% in early trading. By midday, XRTX was changing hands at just over $1.20 per shareragingbull.com. It eventually closed about 21% higher on Fridaytipranks.com – a dramatic move for a company that had been trading quietly near the $1 level.
17 October 2025
·
Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences Stock Soars 40% After FDA Setback Sparks Strategic Shake-Up

Kezar Life Sciences revealed a major regulatory setback for its lead drug and immediately pivoted to consider strategic alternatives. In an October 16 press release, the South San Francisco company announced it failed to reach alignment with the U.S. Food and Drug Administration on the design of a pivotal trial for zetomipzomib in autoimmune hepatitisca.investing.com. The FDA abruptly canceled a Type C meeting that was scheduled for Q4 2025 to discuss Kezar’s proposed Phase 3 trial, and instead requested a new standalone study to characterize zetomipzomib’s pharmacokinetics in patients with severe liver impairmentstocktitan.netstocktitan.net. The agency also mandated 48-hour in-patient monitoring for future trialsca.investing.com – an onerous requirement that Kezar says would likely hinder patient enrollment.
17 October 2025
··
Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine (IRON) Stock Soars on FDA Fast-Track News as Analysts Boost Targets

Disc Medicine’s stock price spiked dramatically in mid-October 2025 after news of the FDA voucher, vaulting from the mid-$70s to the low-$90s in a single daygurufocus.com. On Friday, IRON opened around $85 and surged to an intraday high of $92.50 before closing at $93.00, marking a ~25% jump on the daystockanalysis.com. This leap capped a steady uptrend over the past month – the shares were trading near $60 in early September and gradually climbed into the $70s as anticipation built around bitopertin’s NDA filing and reviewstockanalysis.comstockanalysis.com. The FDA’s award of a priority review voucher was the clear catalyst for the latest rally, as it significantly accelerates Disc’s timeline to a potential approval. The stock’s year-to-date performance now far outpaces broader biotech indices, reflecting how quickly sentiment can turn when a small biotech achieves a major regulatory win.
17 October 2025
·
Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Nebius Group (NBIS) Skyrockets 350% on AI Deal, Then Stumbles – What’s Next for This Cloud Newcomer?

Few stocks captured the AI frenzy of 2025 like Nebius Group. This Amsterdam-headquartered cloud upstart – born from the breakup of Russia’s Yandex – has seen its Nasdaq-listed shares soar by triple digits. Year-to-date, NBIS has climbed roughly +350%, far outpacing broader tech indicests2.tech. The stock hit an all-time high around $132-$135 in early October, a stunning jump from just ~$14 a year agots2.tech. As one analysis noted, Nebius’ high volatility reflects both the massive upside and risks in its growth storyts2.tech.
17 October 2025
···
Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce (CRM) Stock Soars on $60B AI Bet – Can the Cloud Giant’s Rally Last?

Salesforce’s stock has been on a rollercoaster in recent weeks. After a steep September sell-off – when cautious guidance sent shares to multi-month lows around $235ts2.tech – the stock found a footing in the mid-$230s. Heading into mid-October, CRM began to stabilize. On October 16, shares surged about 4% after Salesforce issued a surprisingly strong long-term forecast, lifting the stock to roughly $246 by Thursday’s closereuters.com. That rebound comes as a relief to investors: even after the pop, CRM remains down roughly 27–29% year-to-datereuters.com, a stark contrast to major indexes. In fact, Salesforce has lagged the S&P 500 by over 30 percentage points in the past yearts2.tech, dramatically underperforming many tech peers.
17 October 2025
··
1 … 288 289 290 291 292 … 419
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap Holdings

NYSE: AER 92/100
#2 BUY

Uber Technologies

NYSE: UBER 90/100
#3 BUY

Taiwan Semiconductor Manufacturing

NYSE: TSM 89/100
#4 ACCUMULATE

dLocal

NASDAQ: DLO 86/100
#5 ACCUMULATE

Tapestry

NYSE: TPR 84/100
View full portfolio
Editorial model selection. Not personalised advice.